Global Regulatory Requirements & Standards Flashcards

In the context of global drug approvals, what is a 'reference listed drug' (RLD) primarily used for?

Answer: Defining the branded drug against which generic applicants demonstrate bioequivalence

An RLD is the approved innovator drug product that ANDA applicants must reference and demonstrate bioequivalence to in order to gain FDA generic drug approval.

Australia's TGA uses which application pathway specifically for medicines that have been approved by a comparable overseas regulator?

Answer: Category 3 AUST R application

TGA's Category 3 pathway allows sponsors to rely on an evaluation completed by a recognized comparable overseas regulator, expediting the Australian review.

Which ICH guideline addresses impurity thresholds and qualification requirements for new drug substances?

Answer: ICH Q3A(R2)

ICH Q3A(R2) provides thresholds and guidance for reporting, identifying, and qualifying impurities in new drug substances.

Under EU GMP Annex 11, which principle is critical when using computerized systems in pharmaceutical manufacturing?

Answer: Validation of computerized systems to ensure data integrity and reliability

EU GMP Annex 11 requires that computerized systems used in pharmaceutical manufacturing are validated to ensure data integrity, accuracy, and reliability.

What is the primary purpose of a Type II variation in the EU regulatory framework?

Answer: Major change with significant impact on quality, safety, or efficacy

A Type II variation covers major changes to a marketing authorization that may significantly impact the quality, safety, or efficacy of the product.

ICH M7(R1) specifically addresses which category of impurities in pharmaceutical products?

Answer: Mutagenic (genotoxic) impurities

ICH M7(R1) provides a risk-based approach to assess and control mutagenic (potentially genotoxic) impurities in drug substances and products.

A company wishes to register a pharmaceutical product in multiple African countries. Which organization facilitates regulatory harmonization across African Union member states?

Answer: African Medicines Agency (AMA)

The African Medicines Agency (AMA) was established to harmonize medicines regulation across African Union member states and facilitate mutual recognition of approvals.